[Federal Register Volume 75, Number 188 (Wednesday, September 29, 2010)]
[Notices]
[Pages 60137-60138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-24352]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0006]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested: Application for Individual Manufacturing Quota for 
a Basic Class of Controlled Substance and for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine

ACTION: 30-Day notice of information collection under review.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) has submitted the following information collection request to the 
Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 75, Number 138, 
page 42133 on July 20, 2010, allowing for a 60 day comment period.

[[Page 60138]]

    The purpose of this notice is to allow for an additional 30 days 
for public comment until October 29, 2010. This process is conducted in 
accordance with 5 CFR 1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Mark W. Caverly, Chief, Liaison and Policy 
Section, Office of Diversion Control, Drug Enforcement Administration, 
8701 Morrissette Drive, Springfield, VA 22152.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.
    Overview of this Information Collection 1117-0006:
    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Application for Individual 
Manufacturing Quota for a Basic Class of Controlled Substance and for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189).
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Form Number: DEA Form 
189, Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that 
any person who is registered to manufacture any basic class of 
controlled substances listed in Schedule I or II and who desires to 
manufacture a quantity of such class, or who desires to manufacture 
using the List I chemicals ephedrine, pseudoephedrine, or 
phenylpropanolamine, must apply on DEA Form 189 for a manufacturing 
quota for such quantity of such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes 0.5 hours (30 minutes) to complete. In total, 31 
firms submit 468 responses, with each response taking 0.5 hours (30 
minutes) to complete. This results in a total public burden of 234 
hours annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: In total, 31 firms submit 468 responses, with each 
response taking 0.5 hours (30 minutes) to complete. This results in a 
total public burden of 234 hours annually.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street, NE., Suite 2E-502, Washington, DC 
20530.

     Dated: September 23, 2010.
Lynn Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2010-24352 Filed 9-28-10; 8:45 am]
BILLING CODE 4410-09-P